DaVita
DVA
#1816
Rank
NZ$20.50 B
Marketcap
NZ$319.41
Share price
1.26%
Change (1 day)
44.64%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): NZ$21.72

According to DaVita's latest financial reports the company's current EPS (TTM) is NZ$22.24. In 2025 the company made an earnings per share (EPS) of NZ$18.03 a decrease over its 2024 EPS that were of NZ$19.65.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$21.7220.46%
2025NZ$18.03-8.25%
2024NZ$19.6544.94%
2023NZ$13.5627.26%
2022NZ$10.66-35.56%
2021NZ$16.5444.1%
2020NZ$11.4819.7%
2019NZ$9.59540.48%
2018NZ$1.50-76.07%
2017NZ$6.25-19.31%
2016NZ$7.75242.52%
2015NZ$2.26-62.87%
2014NZ$6.0913.43%
2013NZ$5.378.45%
2012NZ$4.95

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
NZ$44.24 98.96%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$21.69-2.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
NZ$46.54 109.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
NZ$3.77-83.04%๐Ÿ‡บ๐Ÿ‡ธ USA